FDA Approves Efsitora Weekly Insulin for Type 2 Diabetes

(MedPage Today) -- The FDA approved the once-weekly basal insulin efsitora (Onswik), drugmaker Eli Lilly announced on Thursday.
Indicated as an adjunct to diet and exercise for adults with type 2 diabetes, the therapy delivers steady basal insulin...